These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36324078)

  • 81. Chronic inflammatory demyelinating polyneuropathy and HEV antibody status: A case-control study from Lazio, Italy.
    Moret F; Spada E; Ceccanti M; Libonati L; D'Andrea E; Villano U; Madonna E; Chionne P; Carocci A; Pisani G; Fionda L; Antonini G; Petrucci A; Bruni R; Ciccaglione AR; Taliani G; Rivano Capparuccia M; Nobile-Orazio E; Inghilleri M; Cambieri C
    J Neurol Sci; 2024 Apr; 459():122959. PubMed ID: 38490091
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A new treatment regimen with high-dose and fractioned immunoglobulin in a special subgroup of severe and dependent CIDP patients.
    Debs R; Reach P; Cret C; Demeret S; Saheb S; Maisonobe T; Viala K
    Int J Neurosci; 2017 Oct; 127(10):864-872. PubMed ID: 27918219
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
    Hughes R; Dalakas MC; Merkies I; Latov N; Léger JM; Nobile-Orazio E; Sobue G; Genge A; Cornblath D; Merschhemke M; Ervin CM; Agoropoulou C; Hartung HP;
    Lancet Neurol; 2018 Aug; 17(8):689-698. PubMed ID: 30001923
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.
    Tackenberg B; Nimmerjahn F; Lünemann JD
    J Clin Immunol; 2010 May; 30 Suppl 1():S65-9. PubMed ID: 20424898
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
    Iijima M; Koike H; Sobue G
    Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post-hoc analysis of the immunoglobulin overtreatment in CIDP trial.
    van Veen R; Wieske L; Lucke I; Adrichem ME; Merkies ISJ; van Schaik IN; Eftimov F
    J Peripher Nerv Syst; 2022 Jun; 27(2):144-158. PubMed ID: 35507446
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
    Hu W; Xin Y; He Z; Zhao Y
    Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
    Uzenot D; Azulay JP; Pouget J
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Long-term effects of intravenous immunoglobulin in CIDP.
    Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
    Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Sensory CIDP presenting as cryptogenic sensory polyneuropathy.
    Chin RL; Latov N; Sander HW; Hays AP; Croul SE; Magda P; Brannagan TH
    J Peripher Nerv Syst; 2004 Sep; 9(3):132-7. PubMed ID: 15363060
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Progress in Hematopoietic Stem Cell Transplantation for CIDP.
    Qin Z; Huang Q; Zou J; Tang L; Hu Z; Tang X
    Int J Med Sci; 2020; 17(2):234-241. PubMed ID: 32038107
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Autoimmune neuropathies: diagnosis, treatment, and recent topics].
    Ueda M; Kusunoki S
    Brain Nerve; 2011 Jun; 63(6):549-55. PubMed ID: 21613658
    [TBL] [Abstract][Full Text] [Related]  

  • 94. IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
    Ritter C; Förster D; Albrecht P; Hartung HP; Kieseier BC; Lehmann HC
    J Neuroimmunol; 2014 Sep; 274(1-2):225-9. PubMed ID: 25002077
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy.
    Markvardsen LH; Debost JC; Harbo T; Sindrup SH; Andersen H; Christiansen I; Otto M; Olsen NK; Lassen LL; Jakobsen J;
    Eur J Neurol; 2013 May; 20(5):836-42. PubMed ID: 23294032
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical outcome of CIDP one year after start of treatment: a prospective cohort study.
    Bus SRM; Broers MC; Lucke IM; Bunschoten C; van Lieverloo GGA; Adrichem ME; van Veen R; Wieske L; Lingsma HF; Goedee HS; van der Pol WL; van Schaik IN; Van Doorn PA; Jacobs BC; Eftimov F;
    J Neurol; 2022 Feb; 269(2):945-955. PubMed ID: 34173873
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol.
    Cornblath DR; Hartung HP; Katzberg HD; Merkies ISJ; van Doorn PA
    J Peripher Nerv Syst; 2018 Jun; 23(2):108-114. PubMed ID: 29603842
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti-rituximab antibodies.
    Casertano S; Signoriello E; Rossi F; Di Pietro A; Tuccillo F; Bonavita S; Lus G
    Eur J Neurol; 2020 Dec; 27(12):2673-2675. PubMed ID: 32875645
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disorders.
    Broyles R; Rodden L; Riley P; Berger M
    Postgrad Med; 2013 Mar; 125(2):65-72. PubMed ID: 23816772
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years.
    Hiew FL; Ong JJ; Viswanathan S; Puvanarajah S
    J Clin Neurosci; 2018 Apr; 50():203-207. PubMed ID: 29398193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.